436 related articles for article (PubMed ID: 31352078)
41. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
[TBL] [Abstract][Full Text] [Related]
42. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.
Yeo D; Phillips P; Baldwin GS; He H; Nikfarjam M
Int J Cancer; 2017 May; 140(9):2101-2111. PubMed ID: 28109008
[TBL] [Abstract][Full Text] [Related]
44. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
[TBL] [Abstract][Full Text] [Related]
45. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
Saison-Ridinger M; DelGiorno KE; Zhang T; Kraus A; French R; Jaquish D; Tsui C; Erikson G; Spike BT; Shokhirev MN; Liddle C; Yu RT; Downes M; Evans RM; Saghatelian A; Lowy AM; Wahl GM
PLoS One; 2017; 12(12):e0189051. PubMed ID: 29211796
[TBL] [Abstract][Full Text] [Related]
46. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis.
Morvaridi S; Dhall D; Greene MI; Pandol SJ; Wang Q
Sci Rep; 2015 Nov; 5():16759. PubMed ID: 26567630
[TBL] [Abstract][Full Text] [Related]
47. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
48. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J
Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064
[TBL] [Abstract][Full Text] [Related]
49. MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma.
New M; Van Acker T; Sakamaki JI; Jiang M; Saunders RE; Long J; Wang VM; Behrens A; Cerveira J; Sudhakar P; Korcsmaros T; Jefferies HBJ; Ryan KM; Howell M; Tooze SA
Cancer Res; 2019 Apr; 79(8):1884-1898. PubMed ID: 30765601
[TBL] [Abstract][Full Text] [Related]
50. Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells.
Masamune A; Yoshida N; Hamada S; Takikawa T; Nabeshima T; Shimosegawa T
Biochem Biophys Res Commun; 2018 Jan; 495(1):71-77. PubMed ID: 29111329
[TBL] [Abstract][Full Text] [Related]
51. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma.
Koikawa K; Ohuchida K; Ando Y; Kibe S; Nakayama H; Takesue S; Endo S; Abe T; Okumura T; Iwamoto C; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Nagai E; Mizumoto K; Hashizume M; Nakamura M
Cancer Lett; 2018 Jul; 425():65-77. PubMed ID: 29580808
[TBL] [Abstract][Full Text] [Related]
52. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic stellate cell: Pandora's box for pancreatic disease biology.
Bynigeri RR; Jakkampudi A; Jangala R; Subramanyam C; Sasikala M; Rao GV; Reddy DN; Talukdar R
World J Gastroenterol; 2017 Jan; 23(3):382-405. PubMed ID: 28210075
[TBL] [Abstract][Full Text] [Related]
54. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
[TBL] [Abstract][Full Text] [Related]
55. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
[TBL] [Abstract][Full Text] [Related]
56. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
57. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
58. Impact of the secretome of activated pancreatic stellate cells on growth and differentiation of pancreatic tumour cells.
Marzoq AJ; Mustafa SA; Heidrich L; Hoheisel JD; Alhamdani MSS
Sci Rep; 2019 Mar; 9(1):5303. PubMed ID: 30923340
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
60. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
